EBS

Emergent BioSolutions develops medical countermeasures and vaccines for infectious disease threats, including products for anthrax, smallpox, botulism, and viral hemorrhagic fevers. The company's pipeline spans vaccines, immunoglobulins, and antivirals across various development stages, with significant reliance on U.S. government funding and procurement contracts. Manufacturing and regulatory compliance are critical to operations, as evidenced by the company's focus on quality standards across its facilities.

Pipeline

Catalyst Calendar